RecruitingNCT06277362

Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening Ischemia

"Arterial-Venous Reversal Flow in "No-option" Chronic Limb-threating Ischemia (CLTI) Patients"

Sponsor

EndoCore Lab s.r.l.

Enrollment

50 participants

Start Date

Jan 31, 2020

Study Type

OBSERVATIONAL

Conditions

Peripheral Arterial Disease Diabetic Foot Critical Limb-Threatening Ischemia

Summary

The objective of the study is to evaluate early safety and effectiveness of the percutaneous deep foot venous arterialization performed in clinical practice, in an unselected population of patients with "no-option" CLTI.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with critical limb-threatening ischemia, diabetic foot, and other related conditions. The study is currently recruiting participants at 9 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.